- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 8th, 2007
Jeff Williams has no illusions about why he was appointed chief executive of Platypus Technologies. His mission, and the company's mission, is to start actively commercializing the combination "bio" and "nano" technology that has been under development inside its New Venture Center facility.
Platypus, which helps researchers study chemical reactions with the help of nano-structured surfaces, is closer to launching a key assay, and Williams has ample experience bringing products to market at career stops like Roche Diagnostics and Ambion Diagnostics, where he was responsible for the commercialization of several FDA-regulated products.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Personal cooling units on the horizon April 29th, 2016
Exploring phosphorene, a promising new material April 29th, 2016
Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016